Takaki Hiwasa

Toho University — Japan

Immunology and Microbiology · Life Sciences

31h-index3.1kcitations188works1.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atherosclerosis and Cardiovascular Diseases(34), Monoclonal and Polyclonal Antibodies Research(29), Cell Adhesion Molecules Research(26), Glycosylation and Glycoproteins Research(20), Cancer-related Molecular Pathways(18)

Publications188 total

Serum autoantibodies as biomarkers in atherosclerotic disease
Brain & Heart·2025Open Access
Anti-GIP Antibodies and Future Diabetes Risk: Eight-Year Prospective Cohort Study
2025Open Access
Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes
Scientific Reports·2025Open Access
Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes
2025Open Access
Autoantibody against UBE2E3 is a common biomarker for atherosclerotic diseases and digestive tract cancer
Exploration of Cardiology·2025Open Access
Application of serum anti‑ENO1 and anti‑SSNA1 antibody biomarkers in predicting the prognosis of gastric cancer
Oncology Letters·2025· 1 citedOpen Access
Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases
Medicine International·2024· 2 citedOpen Access
Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer
International Journal of Molecular Sciences·2024· 1 citedOpen Access
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases
International Journal of Molecular Sciences·2024· 5 citedOpen Access
Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma
Cancer Science·2024· 2 citedOpen Access
JMJD6 Autoantibodies as a Potential Biomarker for Atherosclerosis-Related Diseases
Preprints.org·2024· 1 citedOpen Access
Combinational antibody detection approach increases the clinical validity of colorectal cancer screening
Journal of Clinical Laboratory Analysis·2023· 2 citedOpen Access
Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus
BMC Endocrine Disorders·2023· 3 citedOpen Access
Atherosclerosis-related biomarker PABPC1 predicts pan-cancer events
Stroke and Vascular Neurology·2023· 9 citedOpen Access
GADD34 activates p53 and may have utility as a marker of atherosclerosis
Frontiers in Medicine·2023· 5 citedOpen Access
Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels
BMC Cancer·2023· 5 citedOpen Access
Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study
Scientific Reports·2023· 5 citedOpen Access
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
Frontiers in Cardiovascular Medicine·2023· 3 citedOpen Access
Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer
Oncology Letters·2023· 5 citedOpen Access
The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
Medicine International·2023· 4 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Masaki Takiguchi(24), Yasuo Iwadate(18), Hideaki Shimada(18), Fumio Nomura(13), Takenori Ochiai(10), Toshio Machida(10), Tomoo Matsutani(10), Hisahiro Matsubara(9), Eiichi Kobayashi(9), Seiichiro Mine(8), Yoichi Yoshida(8), Minoru Takemoto(8), Koutaro Yokote(8), Hirotaka Takizawa(8), Rika Nakamura(7), Natsuko Shinmen(7), Hideyuki Kuroda(7), Mikiko Ohno(7), Eiichiro Nishi(7), Masaaki Ito(7)